The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecules

de la Torre, Beatriz G.Albericio Palomera, Fernando2020-05-062020-05-062017-02-271420-3049https://hdl.handle.net/2445/158950This is an analysis from a chemical point of view of the 22 drugs accepted by the FDA during 2016. The different drugs from the 2016 "harvest" have been classified according to their chemical structure: antibodies; TIDES (oligonucleotides and peptides); amino acids and natural products; drug combination; and small molecules.6 p.application/pdfengcc-by (c) de la Torre, Beatriz G. et al., 2017http://creativecommons.org/licenses/by/3.0/esDisseny de medicamentsPèptidsFarmacologiaDrug designPeptidesPharmacologyThe Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Moleculesinfo:eu-repo/semantics/article6810892020-05-06info:eu-repo/semantics/openAccess28264468